Oncology PracticeFDA Commissioner to Present Keynote Address at NORD Summit August 9, 2017Rare Diseases
Oncology PracticePreview Agenda for NORD’s 2017 Rare Diseases and Orphan Products August 9, 2017Rare Diseases
Hematology TimesTargeting heme synthesis to treat AMLAugust 9, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesAdvanced cancer patients have lower survival after cardiac arrestAugust 9, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesDatabase may provide insight into childhood cancersAugust 9, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Oncology PracticeVIDEO: Lenvatinib’s real-world thyroid cancer performance matches trialAugust 8, 2017Head & Neck/Thyroid Cancers
Oncology PracticeSequential pazopanib and everolimus nets good survival in metastatic RCCAugust 8, 2017Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeACA: Five tactics could lead to implosionAugust 8, 2017Business of MedicinePractice Management
Hematology NewsALLOZITHRO trial: HSCT patients fared worse with azithromycinAugust 8, 2017Cellular TherapyPatient & Survivor Care
Oncology PracticeCalifornia study indicates increased melanoma incidence is realAugust 8, 2017Melanoma
Hematology TimesTeam characterizes RIMs in childhood cancer survivorsAugust 8, 2017Leukemia, Myelodysplasia, TransplantationPediatrics
Hematology TimesDrug granted priority review, breakthrough designation for ECDAugust 8, 2017CythemiasPharmacy
Hematology NewsVemurafenib granted sNDA, priority review for Erdheim-Chester diseaseAugust 7, 2017Myelodysplastic Syndrome
